Deferasirox - NDC Database (Page 3)
62332-324 Nov 21, 2019
Deferasirox 125 mg Oral Tablet, for Suspension by Alembic Pharmaceuticals Inc.
Deferasirox 125 mg Oral Tablet, for Suspension by Alembic Pharmaceuticals Inc.
62332-325 Nov 21, 2019
Deferasirox 250 mg Oral Tablet, for Suspension by Alembic Pharmaceuticals Inc.
Deferasirox 250 mg Oral Tablet, for Suspension by Alembic Pharmaceuticals Inc.
62332-326 Nov 21, 2019
Deferasirox 500 mg Oral Tablet, for Suspension by Alembic Pharmaceuticals Inc.
Deferasirox 500 mg Oral Tablet, for Suspension by Alembic Pharmaceuticals Inc.
62756-568 Dec 02, 2019
Deferasirox 125 mg Oral Tablet, for Suspension by Sun Pharmaceutical Industries, Inc.
Deferasirox 125 mg Oral Tablet, for Suspension by Sun Pharmaceutical Industries, Inc.
62756-569 Dec 02, 2019
Deferasirox 250 mg Oral Tablet, for Suspension by Sun Pharmaceutical Industries, Inc.
Deferasirox 250 mg Oral Tablet, for Suspension by Sun Pharmaceutical Industries, Inc.
62756-570 Dec 02, 2019
Deferasirox 500 mg Oral Tablet, for Suspension by Sun Pharmaceutical Industries, Inc.
Deferasirox 500 mg Oral Tablet, for Suspension by Sun Pharmaceutical Industries, Inc.
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.